US 8841333
Methods for treating nephrolithiasis
granted A61KA61K31/415A61K31/426
Quick answer
US patent 8841333 (Methods for treating nephrolithiasis) held by Takeda Pharmaceuticals U.S.A., Inc. expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceuticals U.S.A., Inc.
- Grant date
- Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/415, A61K31/426, A61P, A61P13/12